Profil
Mei Hui Li currently works at Cinemark Co. Ltd., as Vice Chairman & Chief Executive Officer, CTCI Advanced Systems Inc., as Independent Director from 2014, and Advagene Biopharma Co., Ltd., as Director.
Ms. Li also formerly worked at Taiwan Secom Co., Ltd., as Managing Director and FOCI Fiber Optic Communications, Inc., as Independent Director.
Ms. Li received her graduate degree from National Taiwan University.
Aktive Positionen von Mei Hui Li
| Unternehmen | Position | Beginn |
|---|---|---|
| CTCI ADVANCED SYSTEMS INC. | Direktor/Vorstandsmitglied | 26.06.2014 |
| ADVAGENE BIOPHARMA CO., LTD. | Direktor/Vorstandsmitglied | - |
Cinemark Co. Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Mei Hui Li
| Unternehmen | Position | Ende |
|---|---|---|
| FOCI FIBER OPTIC COMMUNICATIONS, INC. | Direktor/Vorstandsmitglied | - |
| TAIWAN SECOM CO., LTD. | Corporate Officer/Principal | - |
Ausbildung von Mei Hui Li
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Taiwan Secom Co., Ltd.
Taiwan Secom Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides system security services | Commercial Services |
CTCI Advanced Systems Inc.
CTCI Advanced Systems Inc. Electrical ProductsProducer Manufacturing Manufactures control system software and hardware | Producer Manufacturing |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FOCI Fiber Optic Communications, Inc.
FOCI Fiber Optic Communications, Inc. Electrical ProductsProducer Manufacturing Manufactures and sells fiber optic interconnectors | Producer Manufacturing |
Cinemark Co. Ltd. | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
















